person reading Dr. Martin W. Mackay, PhD's salary history.

Historical salary details - Dr. Martin W. Mackay, PhD, Independent Director, Novo Nordisk - ADR

Dr. Martin W. Mackay, PhD is the Independent Director of Novo Nordisk - ADR. They also hold 3 other positions in Charles River Laboratories International Inc., SpringWorks Therapeutics Inc and Rallybio Corp.

Dr. Martin W. Mackay, Phd

Independent Director

$ 1.7 M
Gross Remuneration
  • Current Company

    Novo Nordisk - ADR
YEAR COMPANY POSITION SALARY INCREMENT
2024 Novo Nordisk - ADR Independent Director 1.7 M -8.3 %
2024 Charles River Laboratories International Inc. Independent Director - -
2024 SpringWorks Therapeutics Inc Independent Director - -
2024 Rallybio Corp Chairman of the Board - -
2023 Novo Nordisk - ADR Independent Director 1.8 M -
2023 Charles River Laboratories International Inc. Independent Director 336.0 K 1.9 %
2023 Rallybio Corp Executive Chairman of the Board - -
2022 Charles River Laboratories International Inc. Independent Director 329.8 K 3.7 %
2022 Rallybio Corp Chairman of the Board and Chief Executive Officer - -
2022 Novo Nordisk - ADR Independent Director - -
2021 Charles River Laboratories International Inc. Independent Director 318.1 K -0.1 %
2021 Novo Nordisk - ADR Independent Director - -
2021 Rallybio Corp Chairman of the Board and Chief Executive Officer - -
2020 Charles River Laboratories International Inc. Independent Director 318.4 K 0.3 %
2020 Novo Nordisk - ADR Independent Director - -
2020 Rallybio Corp Chairman of the Board and Chief Executive Officer - -
2019 Novo Nordisk - ADR Independent Director 1.4 M -
2019 Charles River Laboratories International Inc. Independent Director 317.4 K 15.4 %
2018 Charles River Laboratories International Inc. Independent Director 275.0 K 12.2 %
2017 Charles River Laboratories International Inc. Independent Director 245.0 K -